CY1113442T1 - CONNECTORS RELATED TO ERYTHROPETINE RECEPTORS - Google Patents
CONNECTORS RELATED TO ERYTHROPETINE RECEPTORSInfo
- Publication number
- CY1113442T1 CY1113442T1 CY20121101190T CY121101190T CY1113442T1 CY 1113442 T1 CY1113442 T1 CY 1113442T1 CY 20121101190 T CY20121101190 T CY 20121101190T CY 121101190 T CY121101190 T CY 121101190T CY 1113442 T1 CY1113442 T1 CY 1113442T1
- Authority
- CY
- Cyprus
- Prior art keywords
- peptide compounds
- nal
- peptides
- erythropetine
- receptors
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Η παρούσα εφεύρεση σχετίζεται με ενώσεις πεπτιδίων που είναι αγωνιστές του υποδοχέα ερυθροποιητίνης (EPO-R). Η εφεύρεση σχετίζεται επίσης και με θεραπευτικές μεθόδους χρησιμοποιώντας τέτοιες ενώσεις πεπτιδίων για την αγωγή διαταραχών που συσχετίζονται με ανεπαρκή ή ελαττωματική παραγωγή ερυθροκυττάρων αίματος. Φαρμακευτικές συνθέσεις, οι οποίες περιλαμβάνουν τις ενώσεις των πεπτιδίων της εφεύρεσης, παρέχονται επίσης. Τα πεπτίδια μπορούν να είναι σε μονομερικές ή διμερικές μορφές και συζευγνύονται τελικά σε PEG (πολυαιθυλενγλυκόλη, ΣτΜ). Τα πεπτίδια έχουν από 1 έως 40 κατάλοιπα και περιλαμβάνουν την αλληλουχία: LYACHX0GPITX1 VCQPLR, όπου το Χ0 είναι Η ή μεθυλαιθέρας ομοσερίνης · το Χ1 είναι W ή 1-nal ή 2-nal.The present invention relates to peptide compounds that are erythropoietin receptor agonists (EPO-R). The invention also relates to therapeutic methods using such peptide compounds for the treatment of disorders associated with inadequate or defective production of blood red blood cells. Pharmaceutical compositions comprising the peptide compounds of the invention are also provided. The peptides can be in monomeric or dimeric forms and are eventually conjugated to PEG (polyethylene glycol, STM). The peptides have from 1 to 40 residues and include the sequence: LYACHX0GPITX1 VCQPLR, wherein X0 is H or homoserine methyl ether; X1 is W or 1-nal or 2-nal.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47024503A | 2003-05-12 | 2003-05-12 | |
EP04760995A EP1625156B1 (en) | 2003-05-12 | 2004-05-12 | Peptides that bind to the erythropoietin receptor |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1113442T1 true CY1113442T1 (en) | 2016-06-22 |
Family
ID=58448867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20121101190T CY1113442T1 (en) | 2003-05-12 | 2012-12-07 | CONNECTORS RELATED TO ERYTHROPETINE RECEPTORS |
Country Status (1)
Country | Link |
---|---|
CY (1) | CY1113442T1 (en) |
-
2012
- 2012-12-07 CY CY20121101190T patent/CY1113442T1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1109028T1 (en) | NEW PYPTIDES CONNECTED WITH THE ERYTHROPETINE RECEPTOR | |
WO2004101611A3 (en) | Peptides that bind to the erythropoietin receptor | |
CN105308063B (en) | WT1 Antigenic Peptide conjugate vaccine | |
US7268108B2 (en) | Alpha-melanocyte stimulating hormone derivatives and cosmetic application thereof | |
CY1120007T1 (en) | REMORPORATION AND GLYCOPEGYLATION OF GROWTH Fibroblast Factor (FGF) | |
KR20210055694A (en) | IL-2 receptor binding compound | |
CY1113379T1 (en) | KDR Peptides and Vaccines Included | |
EA200300381A1 (en) | NUCLEIC ACIDS AND POLYPEPTIDES OF THE NEW RECEPTOR | |
CY1116370T1 (en) | GLYPRO PROTEIN SOLUBLE SOLUTION (sHASEGP), PROCEDURE FOR USE, USES AND PHARMACEUTICAL COMPOSITIONS INCLUDED | |
PA8497801A1 (en) | Erythropoietin conjugates | |
IT1164225B (en) | INVERTED ANALOGS OF PENTAPEPTIDE ENHANCING BRADICHINA BPP5A AND METHODS FOR THEIR PREPARATION | |
BRPI0717441A2 (en) | COMPOUND, MEDICINAL PRODUCT, AND USE OF THE METASTINE DERIVATIVE | |
CY1106995T1 (en) | BIPID Lipid Nanoparticles for Integration into Peptide Heat / Protein | |
BRPI0619399A2 (en) | metastine derivative or salt thereof, compound or salt thereof, prodrug, medicament, and use of an effective dose of the metastine derivative | |
AR247590A1 (en) | A dna sequence which encodes recombining human factor viii derivatives and a procedure for obtaining them | |
CN110003055A (en) | Dibasic aminoacid containing peptide dressing agent | |
CY1105866T1 (en) | TAMANTARIN AND DIDEMNIN ANALOGUES AND METHODS OF THEIR PREPARATION AND USE | |
BRPI0721259B1 (en) | compost, pharmaceutical composition, use of compost, and process for making compost | |
AR041061A1 (en) | USE OF ERYTHROPOYETIN IN PATIENTS WITH DIABETES | |
CY1111431T1 (en) | METHODS OF PRACTICAL PLUMBING GROWTH FACTORS OF TYPE 1, METHOD OF PREPARATION AND THEIR APPLICATIONS | |
DE602004001727D1 (en) | PROCESS FOR PREPARING CYCLIC PEPTIDES | |
CY1112236T1 (en) | Peptides that are capable of inhibiting the interaction between PRESENILINES and BETA-AMYLOID Peptide or prodrug | |
CN117567639A (en) | Polypeptide conjugates for intracellular delivery of binding peptides | |
BR0009472A (en) | Lhrh antagonists with improved solubility properties | |
KR870008915A (en) | Lenin inhibitors and preparation methods thereof |